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Abstract
Objective: Choosing to undertake a CT scan relies on balancing risk versus benefit, however risks associated with CT
scanning have generally been limited to broad anatomical locations, which do not provided adequate information to
evaluate risk against benefit. Our study aimed to determine differences in radiation dose and risk estimates associated with
modern CT scanning examinations when computed for clinical protocols compared with those using anatomical area.
Methods: Technical data were extracted from a tertiary hospital Picture Archiving Communication System for random
samples of 20–40 CT examinations per adult clinical CT protocol. Organ and whole body radiation dose were calculated
using ImPACT Monte Carlo simulation software and cancer incidence and mortality estimated using BEIR VII age and gender
specific lifetime attributable risk weights.
Results: Thirty four unique CT protocols were identified by our study. When grouped according to anatomic area the
radiation dose varied substantially, particularly for abdominal protocols. The total estimated number of incident cancers and
cancer related deaths using the mean dose of anatomical area were 86 and 69 respectively. Using more specific protocol
doses the estimates rose to 214 and 138 incident cancers and cancer related deaths, at least doubling the burden estimated.
Conclusions: Modern CT scanning produces a greater diversity of effective doses than much of the literature describes;
where a lack of focus on actual scanning protocols has produced estimates that do not reflect the range and complexity of
modern CT practice. To allow clinicians, patients and policy makers to make informed risk versus benefit decisions the
individual and population level risks associated with modern CT practices are essential.
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Introduction
Over the four decades since the introduction of Computed
Tomography (CT) scanning, diagnostic imaging technological
advancements have been a potent factor driving innovations in
medicine [1]. Recent concerns about the radiation dose associated
with CT scanning have led to guidelines, advising on clinical
indications for utilisation and/or reference levels for radiation dose
received from each type of examination[2–4]. Recent studies
reporting the cancer risks of ionizing radiation [5–9] have spurred
intense debate about the risks of diagnostic imaging, and how
these risks ought to be incorporated into the decision making
process[8–12].
Large scale data capture of CT scanner radiation dose in
databases have been proposed to enable institutional benchmark-
ing, optimization of CT protocols, and quality control [9,13].
These data will also enable more accurate patient specific dose
estimation than was possible from previously available data
sources, enabling more accurate patient specific risk assessment
to better inform imaging decisions [9,14].
Estimates of radiation dose and cancer risk from CT scanning
were classically undertaken using ‘typical’ anatomically based CT
protocol/machine settings[5,15–17]. However, the enormous
technological advance in CT scanning has brought diversification
in examination types (protocols) within anatomical locations
subsequently affecting the radiation dose and risk [8,9]. Reliance
on simplistic anatomical location based radiation dosimetry and
derived risk estimates that do not adequately reflect current
practice limits the ability of referring clinicians to make informed
risk: benefit decisions for their patients.
The aim of our study was to examine the radiation dose
associated with modern CT scanning examinations by anatomical
location versus actual clinical protocol to demonstrate the degree
of variation in radiation dose and its impact on population burden
and risk estimates.
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Materials and Methods
Study Design and Setting
A cross-sectional, observational, retrospective study design with
technical CT data collected from a large metropolitan tertiary/
teaching hospital in Western Australia (using two 64-slice CT
machines of the same make and model), via the Picture Archiving
Communication System (PACS), on adult diagnostic CT scanning
protocols (excluding extremities) identified by way of discrete
protocol code/naming conventions used by the institution. Prior to
collection of the data the study was approved by the Western
Australian Department of Health Human Research Ethics
Committee, with a waiver of informed consent for the retrospec-
tive review of electronic medical records.
Data Sources
A random sample of 20 to 40 cases from each protocol
identified was collected on scans performed between 1st January
and 30th April 2011. Rarely fewer than twenty cases were
identified within the collection period; in this event all cases were
included in the study. If the technical parameters appeared
particularly variable up to forty cases were collected. A sample of
20 cases is at least double studies using self-report data have used
[15], comparable to similar studies [9] and conforms to the
European guidelines on the sample required to assess usual patient
doses [18]. Protocol information (excluding the scout view)
consisted of separate scanning sequences (phases) whenever
present. The technical parameters collected included kilovoltage
(kV), milliamperage (mA), tube rotation times, collimation widths,
pitch, scanning method, anatomical reference start-stop positions,
volume weighted CT dose index (CTDIvol) and dose–length
product (DLP).
Radiation Dosimetry
Values of CTDIvol (inclusive of automated tube current
modulation) and DLP were used to calculate the organ specific
dose (mGy) and effective dose (mSv) for each sequence using the
ImPACT dosimetry calculation software [19]. This tool allows
organ and effective dose to be estimated in a population of patients
based on Monte Carlo simulation in an idealized phantom.
Justification of this method and its limitations are presented in the
discussion section. Scan length was obtained by dividing DLP by
CTDIvol present in each case’s dose report. Where ImPACT gave
slightly different values of CTDIvol to those reported by the
machine, the effective dose given by ImPACT was corrected by
the ratio of the reported CTDIvol and the ImPACT estimate.
Cumulative protocol values of CTDIvol, DLP, organ dose and
effective dose were calculated by summation of all sequences
reported for each case. The mean, minimum and maximum
values for each parameter were reported for each protocol and
anatomical area.
Cancer Risk Modelling
The age and gender specific lifetime attributable risk (LAR)
inferable from a single exposure was estimated for the mean,
lowest and highest dose across protocols and each anatomical area.
This was achieved using the protocol specific organ dose and the
age/sex-specific risk coefficients from tables 12D-1 and 12D-2 of
the BEIR VII report [20]. The LAR of cancer incidence and
mortality resulting from radiation dose to the remainder and
‘other’ organs was calculated using doses for organs not named in
the BEIR VII LAR tables but have a weight by International
Commission on Radiological Protection (ICRP) 103 [21], or are
included in the remainder organs by ICRP 103, and weighting
them by the risk attributed by BEIR VII for ‘other’ organs. This
method assumes all such organs contribute equally to risk. The
analysis was repeated for all combinations of age (ranging from 18
to 80 years) in yearly increments, using linear interpolation of the
BEIR VII risk coefficients from the two nearest tabulated ages
when data were not available for a specific age. To estimate the
cancer incidence risk and cancer related mortality attributable to
CT scanning for persons aged over 80 years the linear
interpolation was extended until the estimated number of cancers
or mortality reached zero for each protocol using the same method
described above. The age and gender specific count of CT
scanning procedures performed in Western Australia obtained
from Medicare Australia and WA PACS data were used to
estimate the number of incident cancers and cancer related
mortality attributable to CT.
Results
Radiation Dose Associated with CT Protocols
Table 1 shows a summary of data recorded for each CT
scanning protocol in the study. There was wide variation in the
radiation dosimetry associated with each protocol not completely
attributable to the number of sequences. Protocols for temporal
bone, sinuses (non-contrast), abdomen for renal colic, abdomen/
pelvis, pelvis (non-contrast), chest/abdo/pelvis, thoracic and
lumbar spine CT scanning consistently included only a single
sequence. However, the maximum to minimum ratios indicated a
large variation in radiation dose. Table 1 also presents the mean
and range of radiation dose attributable to CT scanning according
to anatomical area, ‘all protocols,’ where highly variable with
maximum to minimum ratios ranging from 4 (CTDIvol for chest/
abdo/pelvis) to 91 (DLP for Abdominal CT) were observed.
Figure 1 shows a summary of the mean total and organ specific
effective doses attributable to cases collected for the CT scanning
protocols included in the study. Note, for simplicity some protocols
have been paired (+/2 contrast) where no substantive differences
were discernible resulting in 25 bars for the total 34 clinical
protocols identified in Table 1. Visceral spiral (helical) angiogra-
phy produced the highest mean effective whole body dose of
31.2 mSv, while CT of the sinuses produced the lowest mean
effective dose (0.4 mSv). Of the 34 individual protocols, 11 (32%)
produced mean effective doses greater than 10 mSv. Four
protocols (12%) produced mean effective doses in excess of
15 mSv while two (6%) produced mean effective doses in excess of
20 mSv. Only seven protocols (20%) produced mean effective
doses of less than 2 mSv. Only one protocol (visceral spiral
angiography) produced a mean organ specific dose contribution
greater than 6 mSv (6.2 mSv to the stomach). This protocol’s total
effective dose also comprised 5.6 mSv from the colon and 4.1 mSv
from the remainder organs. Thoracic spine CT was the only other
protocol to include an organ specific dose contribution greater
than 5 mSv (5.6 mSv from the lung). Several protocols produced
specific organ contributions to effective dose between 4 and
5 mSv, these were: cardiac non-coronary spiral (helical) angiog-
raphy (4.7 mSv from the breast and 4.6 mSv from the lung), CT
of the thoracic spine (4.6 mSv from the breast), and CT of the
cervical spine (4.2 mSv from the thyroid). When evaluating the
effective doses according to anatomical area a wide variation was
observed with the largest variation noted for abdominal protocols
and the lowest variation in head closely followed by facial bone
protocols.
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Variation in the LAR (Expressed as a Percentage) of
Cancer Incidence and Cancer Related Mortality Across
Anatomical Areas
As expected there was a large variation in the estimated risk of
incident cancers and cancer related mortality across anatomical
areas (Figure 2) driven by differences in the radio-sensitivity of the
organs included within the scanning field, the radiation dose
generated by the CT protocol and gender. The estimated risk of
incident cancers and cancer related mortality was considerably
higher in females compared with males, except for CT scanning of
the pelvis where the estimated risk of cancer for females was
consistently lower than males. The largest difference across
genders was consistently observed for chest CT. Using the mean
dose protocol, females at age 20 years had a 0.25% risk of cancer
compared with 0.09% for males and a 0.12% risk of cancer related
death compared with 0.06% for males. The magnitude of this
difference is highly subject to the dose scenario evaluated, for
example when the protocol giving the maximum dose was
evaluated (end of the bars in Figure 2) females at age 20 years
were estimated to have a 0.94% risk of incident cancers compared
with 0.33% for males and a 0.43% risk of cancer related deaths
compared with 0.22% for males.
When anatomical area mean dose was considered (black lines in
Figure 2), facial bones CT was attributed the lowest risk of incident
cancers and cancer related mortality while chest/abdo/pelvis CT
was attributed the highest risk of incident cancers and cancer
related mortality. This ranking of anatomical areas varied
dependent on both the radiation dose scenario and to a lesser
extent age at CT scan.
Impact of the Dose Scenario on Burden of Cancer and
Cancer Related Mortality Attributable to CT Scanning
Table 2 shows a demonstration of the number of incident
cancers and cancer related mortality attributable to selected CT
scanning examinations, using doses derived from anatomical area
versus clinical protocols. If the mean dose derived from protocols
within each anatomical area was used as the input to the risk
modelling, 86 incident cancers and 69 cancer related deaths were
estimated to be attributable to the independent effect (unadjusted
for competing risk factors not considered in the BEIR VII risk
model) of CT scanning radiation dose. However, using actual
protocol doses the estimates rose to 214 and 138 incident cancers
and cancer related deaths, an increase of a factor of 2.5 and 2.0
respectively. The range of predicted cancers was highly variable
for anatomical areas comprising multiple protocols with four
anatomical areas providing estimates varying by over 10 (cancers)
predicted between the anatomical area estimate and individual
protocol estimates. The largest difference in the anatomical area
and protocol estimates was in abdomen CT. Large maximum to
minimum ratios were also observed in six anatomical areas, with
four having a maximum to minimum ratios of greater than 50, one
exceeding 600 (abdomen).
Discussion
Decisions regarding whether to undertake a particular diagnos-
tic imaging test should always be made balancing risks against
potential benefits. Given the there may be strategies which may
incur lower radiation dose while still affording an acceptable level
of diagnostic accuracy for the particular clinical circumstance,
comprehensive information regarding radiation dose and risk
associated with modern CT scanning is required. This is
particularly important in patients where the magnitude of the risk
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and women). Our study has provided comprehensive information
about the radiation dose and risk burden of modern CT scanning
in order to facilitate incorporation into clinical decision making.
This study has demonstrated modern CT practice comprises
multiple protocols, across most anatomical areas, resulting in a
wide range of radiation doses. This variation in radiation dose
interacted substantially with the lifetime attributable risk ascribed
to ionising radiation, greatly influencing the number of incident
cancers and cancer related mortality estimated to be associated
with CT scanning. The effective radiation dose, and subsequent
risk, resulting from a single CT examination is highly dependent
on machine parameters (ie the protocol used) and the radiosen-
sitivity of the anatomical area scanned. Both of these factors need
to be considered when dosimetric and risk assessments are
undertaken. Using anatomical area for dose and risk estimates
does not accurately account for the significant differences between
protocols. The end result is an inaccurate perception of risk to
individual patients but also the impact of CT radiation burden at a
population level.
The majority of authors when reporting CT radiation dose
either state a broad range (eg 10 to 100 mGy [22]) or provide a
series typical doses for each anatomical area [23], while some
authors have quantified differences in effective dose produced in
limited scenarios by changing certain technical parameters [24].
However, only a few studies have previously published limited
range of protocol specific dose observations, either using survey
data or directly collected from PACS dose reports [8,9]. Our study
has also demonstrated variation in intra-protocol dose suggesting
patient specific modification of technical settings occurs, most
likely based on either clinical requirements or patient habitus. This
finding is welcome in response to concerns in the literature over
the lack of modification of standard protocols with respect to body
habitus and thus potential over-exposure of patients [4]. While we
cannot definitively determine the intra-protocol variation observed
in our study was due to patient characteristics, it is a plausible
explanation for our observations.
A limitation of our study is that our method of estimating
effective and organ dose did not include size specific dose
estimation (SSDE) methods since information regarding the body
habitus of the patients included in the study were not available.
However, for this study the use of SSDE would not change the
(numerical) deviation between the two methods because it
concerns the same patient groups. In addition, while it is very
important to account for patient size when estimating individual
patient radiation dose [25], effective dose is intended to represent
the dose to a population of patients (as we have done in our study)
not individual patient dose [26]. This is an important distinction
since effective dose is derived from measurements in an idealized
phantom that integrates the relative weighting of the radiosensitive
organs exposed and does not reflect the morphometrics of an
individual patient [26]. All estimates of radiation dose have
limitations, for example SSDE does not take into account
Figure 1. Mean whole body and organ specific effective doses (mSv) for selected CT scanning examinations performed in a Western
Australian tertiary public hospital in 2011.
doi:10.1371/journal.pone.0097691.g001
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variations in dose based on variations in scan length, assumes
patients are centred in the CT gantry so that magnification effects
are minimized and cannot be used for estimation of organ dose,
and thus cannot be used to estimate effective dose [26]. Thus while
SSDE is recommended and appropriate for estimating individual
patient radiation dose it is not suitable when organ and effective
dose estimates are required and is not necessary when estimating
the average radiation dose characteristics of a particular exami-
nation ie examination specific rather than patient specific
dosimetry is required.
In our study we aimed to estimate the average effective
radiation dose for each adult CT protocol using a random sample
of adult patients. The use of random sampling methodology was
used to capture any underlying variation in doses produced for
each scanning protocol, comparable to other published research
[9], and avoid recall or selection bias associated with the use of
survey methods. Additionally, the use of actual scan parameters
and dosimetry information recorded at the time of imaging rather
than reliance on self-selected mean doses, ‘standard’ protocols or
phantoms facilitate a more accurate representation of actual dose
Figure 2. Variation in the lifetime attributable risk percent of cancer incidence (light bars) and mortality (dark bars) according to
gender and age at a single exposure from CT scanning protocols grouped according to anatomical location.
doi:10.1371/journal.pone.0097691.g002
Anatomical vs Clinical CT Dose Estimates and Risk
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in practice. Our data source and sampling method provide a more
rigorous picture of real CT practice, rather than idealised or
theoretical CT doses and practices.
Detailed information regarding patient numbers according to
CT protocols from routinely captured administrative data has
allowed for cancer and cancer related mortality attributable to CT
scanning to be estimated, for individual protocols and by
anatomical area. The risk estimates reported in this study are
not based on epidemiological data of actual malignancies in
populations of patients receiving CT scans (such information is
unavailable). The estimates are extrapolations of the attributable
cancer risk models developed in the BEIR VII report [20] using
standard Monte Carlo methods modelling photon transport in
CT. This study employs previously used methods to estimate risk
and are the best available given available data [16]. Our
estimation of the number of incident cancers and cancer related
mortality attributable to CT scanning assumed all providers would
give identical doses. Similar assumptions have been used in these
types of estimates previously [27]. However, the focus of this study
was not to estimate the actual risk of cancer and cancer related
mortality but to demonstrate the impact on risk estimates from
inter-protocol variation versus aggregation of CT protocols to
anatomical areas.
While the BEIR VII report provides a framework for estimating
age, sex and organ specific cancer risks from a radiation exposure
it does not fully account for underlying pathology and life
expectancy. The BEIR VII risks should be considered represen-
tative of the independent effect of radiation dose and can only be
said to account for competing risks included in the original BEIR
VII models. The estimated number of incident cancers and cancer
related mortality are presented here as a demonstration of the
magnitude of the effect on risk estimates of using protocol rather
than anatomic area dose. There is substantial difficulty in
estimating population cancer risk as noted by the International
Organization for Medical Physics (IOMP) [28]. In our study the
imprecision is equally applied to both dose scenarios (anatomical
and protocol) hence the magnitude of the effect of using a
simplistic generalised method (ie anatomic based) over a more
comprehensive and clinically realistic model (protocol based) is not
affected by the concerns of the IOMP. These concerns primarily
rest with debate regarding acceptance of the ‘linear, no-threshold
theory’ for ionising radiation exposure risk. The linear, no-
threshold theory forms the foundation for radiation protection
recommendations by international and national committees
[20,21,29]. Criticism of the linear, no-threshold theory rest on
statistical uncertainty for the relationship between radiation
exposure and cancer incidence at low doses (less than 100 mSv)
[12,21]. However, current biological evidence does not support a
threshold model where exposure to sub-100 mSv radiation doses
represent no risk [20,29,30]. Additionally, other studies estimating
the cancer incidence resulting from the independent effects of CT
radiation exposure have been published using the linear, no-
threshold theory and BEIR-VII LAR estimates [6,8]. Therefore
our study has employed conservative, clinically representative,
peer-reviewed and internationally recognised methodology for
dose and risk estimation.
Conclusion
Radiation dose and risks associated with CT scanning have
commonly been presented using broad anatomical locations
without consideration for the diversity of modern CT examina-
tions performed within each region. This leaves referring clinicians
and patients with limited or simplistic information to evaluate risk
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presenting radiation dose according to anatomical areas, rather
than specific CT protocols, using rigorous CT technical data
sources and established risk estimation methods. Lack of focus on
actual clinical scanning protocols has produced dose estimates that
do not reflect current clinical practice, therefore to improve risk
versus benefit decision making differentiation of the associated
radiation dose resulting from the variety of services present in
modern CT is essential.
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